Top Markets
Coin of the day
Jiangsu Hengrui Medicine Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

600276
Ранг среди акций #510
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Цена акции
$7.88
Рыночная капитализация
$50.25B
Изменение (1 день)
0.00%
Изменение (1 год)
-9.73%
Страна
CN
Торговля Jiangsu Hengrui Medicine Co., Ltd. (600276)

Категория

Коэффициент P/B для Jiangsu Hengrui Medicine Co., Ltd. (600276)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Jiangsu Hengrui Medicine Co., Ltd., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Jiangsu Hengrui Medicine Co., Ltd. с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов